FOXM1 and colon adenocarcinoma: In relation to miR-320 and miR-199a-3p, the high expression levels reported in our study could be related to enhanced drug sensitivity of human TOS by targeting, for example, FOXM1, as reported for colon adenocarcinoma by Wan L. Y et al. [92], and by binding the 3′-UTR region of CD44, as reported by Gao Y. et al. [79].